Training Session: Alternatives to Hazard Ratio for Quantifying Treatment Effect on Time-to-Event Outcomes

Address to event

CLSB 11081
3 Blackfan Circle, 11th floor

Speaker:

Hajime Uno, PhD
Assistant Professor, Department of Data Sciences and Population Sciences

Hazard ratio (HR) has been routinely used to summarize the treatment effect in almost all cancer clinical trials with time-to-event outcomes. However, there is no universally superior method. HR is not an exception. In this training session, I will talk about issues of HR and introduce several alternative summary measures. 

Go to Event Web Page